Source:http://linkedlifedata.com/resource/pubmed/id/14659030
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2003-12-8
|
| pubmed:abstractText |
The standard treatment for early-stage non-small-cell lung cancer is surgical resection. However, many patients are inoperable due to medical comorbidities. Thirty-two medically inoperable patients with early-stage non-small-cell lung cancer were treated with 3-dimensional conformal radiation therapy between January 1991 and December 2000. The median dose was 70.2 Gy, and the median follow-up time in survivors was 30 months. The 2-year actuarial local control, overall survival, and cancer-specific survival rates were 43%, 54%, and 57%, respectively. The 5-year actuarial local control, overall survival, and cancer-specific survival rates were 43%, 33%, and 39%, respectively. This report suggests that local control is improved with high-dose conformal radiation therapy when compared to other institutions' retrospective experiences.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:status |
PubMed-not-MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
1525-7304
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
3
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
141-4
|
| pubmed:dateRevised |
2008-12-12
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
Three-dimensional conformal radiation therapy (3D-CRT) for early-stage non-small-cell lung cancer.
|
| pubmed:affiliation |
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. rosenzwk@mskcc.org
|
| pubmed:publicationType |
Journal Article
|